Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by reducing K63‐specific ubiquitination
This article is part of a themed issue Drugs and Drug Targets in Metabolic and Chronic Inflammatory Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.20/issuetoc.
Authors
- Shao‐Ru Chen
- Chengqing Ning (ORCID: https://orcid.org/0000-0001-6496-8326)
- Jing Xu (ORCID: https://orcid.org/0000-0002-5304-7350)
- Mo‐Yu Ding
- Ying Wang (ORCID: https://orcid.org/0000-0002-1407-2668)
- Haoran Yin (ORCID: https://orcid.org/0000-0002-6307-9591)
Institutions
- University of Macau (MO)
- Southern University of Science and Technology (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1111/bph.17320
- Citations
- 6
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Science, Technology and Innovation Commission of Shenzhen Municipality